Related references
Note: Only part of the references are listed.Splenectomy and the incidence of venous thromboembolism and sepsis in patients with immune thrombocytopenia
Soames Boyle et al.
BLOOD (2013)
Prevalence of pneumococcal vaccination in adult immune thrombocytopenia patients exposed to rituximab or to splenectomy
Guillaume Moulis et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2013)
Safety and efficacy of splenectomy in over 65-yrs-old patients with immune thrombocytopenia
Jose R. Gonzalez-Porras et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2013)
Splenectomy as a curative treatment for immune thrombocytopenia: a retrospective analysis of 233 patients with a minimum follow up of 10 years
Nicola Vianelli et al.
HAEMATOLOGICA (2013)
A pilot randomized trial of adjuvant rituximab or placebo for nonsplenectomized patients with immune thrombocytopenia
Donald M. Arnold et al.
BLOOD (2012)
How I treat immune thrombocytopenia: the choice between splenectomy or a medical therapy as a second-line treatment
Waleed Ghanima et al.
BLOOD (2012)
Outcomes 5 years after response to rituximab therapy in children and adults with immune thrombocytopenia
Vivek L. Patel et al.
BLOOD (2012)
Risk of arterial thrombosis in patients with primary chronic immune thrombocytopenia: a Danish population-based cohort study
Mette Norgaard et al.
BRITISH JOURNAL OF HAEMATOLOGY (2012)
Rituximab before splenectomy in adults with primary idiopathic thrombocytopenic purpura: a meta-analysis
Sophie Auger et al.
BRITISH JOURNAL OF HAEMATOLOGY (2012)
Analyse épidémiologique de 250 patients atteints de purpura thrombopénique immunologique ayant reçu du rituximab. Premiers résultats du registre national prospectif observationnel « PTI-Ritux »
M. Khellaf et al.
REVUE DE MEDECINE INTERNE (2012)
Characteristics and outcome of immune thrombocytopenia in elderly: Results from a single center case-controlled study
Marc Michel et al.
AMERICAN JOURNAL OF HEMATOLOGY (2011)
Long-term clinical outcomes of patients with primary chronic immune thrombocytopenia: a Danish population-based cohort study
Mette Norgaard et al.
BLOOD (2011)
The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia
Cindy Neunert et al.
BLOOD (2011)
Risk of venous thromboembolism in patients with primary chronic immune thrombocytopenia: a Danish population-based cohort study
Marianne T. Severinsen et al.
BRITISH JOURNAL OF HAEMATOLOGY (2011)
Portal Vein Thrombosis After Laparoscopic and Open Splenectomy
Rosario Vecchio et al.
JOURNAL OF LAPAROENDOSCOPIC & ADVANCED SURGICAL TECHNIQUES (2011)
International consensus report on the investigation and management of primary immune thrombocytopenia
Drew Provan et al.
BLOOD (2010)
Mortality risk in splenectomised patients: A Danish population-based cohort study
Mellissa Yong et al.
EUROPEAN JOURNAL OF INTERNAL MEDICINE (2010)
Comorbidities in patients with persistent or chronic immune thrombocytopenia
Cheryl Enger et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2010)
Short-term and long-term failure of laparoscopic splenectomy in adult immune thrombocytopenic purpura patients: A systematic review
Joseph Mikhael et al.
AMERICAN JOURNAL OF HEMATOLOGY (2009)
Risk for Hospital Contact With Infection in Patients With Splenectomy A Population-Based Cohort Study
Reimar W. Thomsen et al.
ANNALS OF INTERNAL MEDICINE (2009)
Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group
Francesco Rodeghiero et al.
BLOOD (2009)
Rituximab efficacy and. safety in adult splenectomy candidates with chronic immune thrombocytopenic purpura:: results of a prospective multicenter phase 2 study
Bertrand Godeau et al.
BLOOD (2008)
Rituximab therapy in adult patients with relapsed or refractory immune thrombocytopenic purpura: long-term follow-up results
Marta Medeot et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2008)
Comparing treatment effects after adjustment with multivariable Cox proportional hazards regression and propensity score methods
Edwin P. Martens et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2008)
Systematic review: Efficacy and safety of rituximab for adults with idiopathic thrombocytopenic purpura
Donald M. Arnold et al.
ANNALS OF INTERNAL MEDICINE (2007)
Results of multivariable logistic regression, propensity matching, propensity adjustment, and propensity-based weighting under conditions of nonuniform effect
T Kurth et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2006)
Splenectomy for adult patients with idiopathic thrombocytopenic purpura: a systematic review to assess long-term platelet count responses, prediction of response, and surgical complications
K Kojouri et al.
BLOOD (2004)
Long term follow-up after splenectomy performed for immune thrombocytopenic purpura (ITP)
J Schwartz et al.
AMERICAN JOURNAL OF HEMATOLOGY (2003)
Rituximab chimeric anti-CD20 monoclonal antibody treatment for adults with chronic idiopathic thrombocytopenic purpura
R Stasi et al.
BLOOD (2001)
The bleeding risk and natural history of idiopathic thrombocytopenic purpura in patients with persistent low platelet counts
YC Cohen et al.
ARCHIVES OF INTERNAL MEDICINE (2000)
Share Paper
